Zydus Lifesciences Ltd.
|
Nine Months RESULTS
|
|
You can view the
Nine Months Results
for the last 5 years.
Market Cap. (Rs.)
|
95330.61 Cr.
|
P/BV
|
5.44
|
Book Value (Rs.)
|
174.07
|
52 Week High/Low (Rs.)
|
1032/485
|
FV/ML
|
1/1
|
P/E(X)
|
48.63
|
Bookclosure
|
28/07/2023
|
EPS (Rs.)
|
19.48
|
Div Yield (%)
|
0.63
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 14013.60 | 12569.70 | 11465.20 | 11255.50 | 10184.90 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 316.10 |
Total Income From Operations | 14013.60 | 12569.70 | 11465.20 | 11255.50 | 10501.00 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 3370.20 | 2912.90 | 3010.90 | 2858.90 | 2425.80 |
Purchase of Traded Goods | 1355.00 | 1465.90 | 1335.80 | 1069.20 | 1220.10 |
Increase/Decrease in Stocks | -108.50 | 235.30 | -242.30 | -62.00 | 14.40 |
Employees Cost | 2300.60 | 2041.70 | 1887.40 | 1879.60 | 1805.50 |
Depreciation | 558.80 | 544.10 | 550.70 | 536.20 | 518.00 |
Other Expenses | 3342.50 | 3309.60 | 2927.10 | 3024.10 | 3084.40 |
Total Expenses | 10818.60 | 10509.50 | 9469.60 | 9306.00 | 9068.20 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 3195.00 | 2060.20 | 1995.60 | 1949.50 | 1432.80 |
Other Income | 127.70 | 148.80 | 145.70 | 77.50 | 69.60 |
P/L Before Interest, Excpt. Items & Tax | 3322.70 | 2209.00 | 2141.30 | 2027.00 | 1502.40 |
Interest | 46.60 | 102.20 | 88.50 | 140.20 | 259.30 |
P/L Before Exceptional Items & Tax | 3276.10 | 2106.80 | 2052.80 | 1886.80 | 1243.10 |
Exceptional Items | -14.20 | -2.90 | -95.70 | -132.00 | -269.70 |
P/L Before Tax | 3261.90 | 2103.90 | 1957.10 | 1754.80 | 973.40 |
Tax | 656.30 | 450.60 | 352.20 | 348.80 | 211.30 |
P/L After Tax from Ordinary Activities | 2605.60 | 1653.30 | 1604.90 | 1406.00 | 762.10 |
Extra Ordinary Item | 19.80 | -2.40 | 2518.50 | 0.00 | 0.00 |
Net Profit/Loss For the Period | 2625.40 | 1650.90 | 4123.40 | 1406.00 | 762.10 |
Share Of P/L Of Associates | 101.30 | 82.80 | 41.60 | 43.60 | 28.60 |
Net P/L After Minority Interest & Share Of Associates | 2726.70 | 1733.70 | 4165.00 | 1449.60 | 790.70 |
| | | | | |
Equity Share Capital | 101.20 | 101.20 | 102.40 | 102.40 | 102.40 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 26.45 | 16.36 | 39.95 | 14.21 | 7.67 |
Diluted EPS (Rs.) | 26.45 | 16.36 | 39.95 | 14.21 | 7.67 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 26.45 | 16.36 | 39.95 | 14.21 | 7.67 |
Diluted EPS (Rs.) | 26.45 | 16.36 | 39.95 | 14.21 | 7.67 |
| | | | | |
PBITOE Margin (%) | 22.79 | 16.39 | 17.40 | 17.32 | 13.64 |
PBTE Margin (%) | 23.37 | 16.76 | 17.90 | 16.76 | 11.83 |
PBT Margin (%) | 23.27 | 16.73 | 17.06 | 15.59 | 9.26 |
PAT Margin (%) | 18.73 | 13.13 | 35.96 | 12.49 | 7.25 |
PAT After MI And SOA Margin (%) | 19.45 | 13.79 | 36.32 | 12.87 | 7.52 |